Peter F A Mulders Selected Research

Peter F A Mulders Research Topics

Disease

44	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 02/2002
35	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 02/2007
32	Neoplasms (Cancer) 01/2023 - 11/2002
8	Neoplasm Metastasis (Metastasis) 07/2018 - 05/2009
3	Kidney Neoplasms (Kidney Cancer) 01/2016 - 10/2011
3	Disease Progression 01/2015 - 09/2005
2	Pain (Aches) 03/2024 - 11/2014
2	Margins of Excision 02/2019 - 08/2015
2	Lymphatic Metastasis 07/2017 - 05/2009
2	Carcinoma (Carcinomatosis) 01/2017 - 01/2016
2	Heart Diseases (Heart Disease) 11/2015 - 02/2015
2	Cancer Pain 10/2015 - 01/2013
1	Postoperative Pain 03/2024
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 10/2017
1	Neoplasm Micrometastasis 01/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2017
1	Flatulence 01/2016
1	Diarrhea 01/2016
1	Colic (Abdominal Cramps) 01/2016
1	Heartburn (Pyrosis) 01/2016
1	Duodenitis 01/2016
1	Thrombosis (Thrombus) 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Hypertension (High Blood Pressure) 02/2015
1	Necrosis 02/2015
1	Seizures (Absence Seizure) 01/2015
1	Fatigue 01/2015
1	Nausea 01/2015

Drug/Important Bio-Agent (IBA)

17	Carbonic Anhydrase IXIBA 05/2022 - 09/2003
15	G250 monoclonal antibodyIBA 01/2023 - 09/2003
12	Abiraterone AcetateIBA 07/2018 - 01/2013
11	Monoclonal AntibodiesIBA 01/2018 - 09/2005
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2014
10	AntigensIBA 01/2017 - 07/2003
9	Prostate-Specific Antigen (Semenogelase)IBA 12/2020 - 02/2007
6	Sunitinib (Sutent)FDA Link 10/2022 - 01/2009
6	Prednisone (Sone)FDA LinkGeneric 07/2017 - 01/2013
6	AntibodiesIBA 01/2016 - 07/2003
6	Sorafenib (BAY 43-9006)FDA Link 03/2014 - 01/2009
5	Radioisotopes (Radionuclides)IBA 05/2022 - 09/2003
5	AndrogensIBA 01/2017 - 01/2013
5	Tyrosine Kinase InhibitorsIBA 01/2016 - 04/2008
4	Messenger RNA (mRNA)IBA 01/2022 - 09/2014
4	enzalutamideIBA 07/2018 - 01/2015
4	Proteins (Proteins, Gene)FDA Link 10/2017 - 07/2003
3	LutetiumIBA 01/2016 - 09/2013
3	Docetaxel (Taxotere)FDA Link 01/2015 - 05/2014
2	Fluorescent Dyes (Fluorescent Probes)IBA 10/2017 - 01/2016
2	Dutasteride (Avodart)FDA Link 01/2016 - 11/2009
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2016 - 11/2010
2	Indium-111IBA 01/2016 - 06/2013
2	Opiate AlkaloidsIBA 10/2015 - 01/2013
2	Testosterone (Sustanon)FDA Link 01/2015 - 07/2013
2	abirateroneIBA 11/2014 - 01/2013
2	Interleukin-2 (IL2)IBA 02/2010 - 11/2002
2	Dihydrotachysterol (AT 10)IBA 12/2009 - 02/2009
1	Analgesics (Analgesic Drugs)IBA 03/2024
1	Lutetium-177IBA 05/2022
1	Actinium-225IBA 05/2022
1	Immunoconjugates (Immunoconjugate)IBA 05/2022
1	Indocyanine Green (Cardio-Green)FDA LinkGeneric 12/2018
1	Denosumab FDA Link 07/2018
1	Radium-223IBA 07/2018
1	Diphosphonates (Bisphosphonates)IBA 07/2018
1	Cell-Free Nucleic AcidsIBA 01/2018
1	Folate Receptor 1IBA 10/2017
1	farletuzumabIBA 10/2017
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017
1	AcidsIBA 01/2017
1	SuspensionsIBA 01/2017
1	labetuzumabIBA 01/2017
1	NivolumabIBA 04/2016
1	Everolimus FDA Link 04/2016
1	bicalutamide (Casodex)FDA LinkGeneric 01/2016
1	Capsules (Microcapsules)IBA 01/2016
1	Pentetic Acid (DTPA)FDA LinkGeneric 08/2015
1	Alanine Transaminase (SGPT)IBA 02/2015
1	Hormones (Hormone)IBA 01/2015
1	Coloring Agents (Dyes)IBA 06/2014
1	N 30IBA 03/2014

Therapy/Procedure

19	Therapeutics 10/2022 - 09/2003
16	Castration 07/2018 - 01/2013
10	Drug Therapy (Chemotherapy) 07/2017 - 11/2007
8	Nephrectomy 02/2019 - 02/2002
7	Radioimmunotherapy 10/2022 - 09/2005
6	Immunotherapy 01/2019 - 02/2002
3	Aftercare (After-Treatment) 01/2017 - 01/2012
2	Life Support Care 10/2015 - 11/2014
2	Neoadjuvant Therapy 07/2011 - 11/2010
1	Length of Stay 03/2024
1	Prostatectomy (Retropubic Prostatectomy) 11/2020
1	Cryosurgery 01/2020
1	Cystectomy 01/2019
1	Conservative Treatment 08/2018
1	Intravenous Injections 01/2017
1	Retreatment 01/2016
1	Duration of Therapy 01/2016
1	Drug Tapering 11/2015
1	Computer-Assisted Surgery (Image Guided Surgery) 08/2015